PERTUSSIS TOXIN

PERTUSSIS TOXIN
  • CAS No.:70323-44-3

Important Notice

  1. This product is a chemical product/pharmaceutical intermediate. It is not a drug, an active pharmaceutical ingredient (API), or a pharmaceutical-grade material. It has not been granted a drug approval number or a Chemical Drug Substance Approval Notice, has not passed drug-related review and approval, and is not manufactured, tested, or released in accordance with pharmaceutical GMP.
  2. This product is intended solely for non-clinical research, process development, quality studies, further chemical processing, or chemical synthesis. It must not be used in drug-product manufacturing, clinical trials, clinical diagnosis, or administration to humans or animals, or be sold, used as an input, submitted for regulatory filing, or released as an API or pharmaceutical material.
  3. The purchaser must not use this product, or supply it to another party, for personal consumption, sports or fitness, weight loss, health supplements, food, or animal feed.
Other grades of this product :
PERTUSSIS TOXIN Basic information
Product Name:PERTUSSIS TOXIN
Synonyms:histamine-sensitizingfactor;iap;Protein-based AB5-type exotoxin with five dissimilar subunits: S-1 (M.W. 28 kDa), S-2 (M.W. 23 kDa), S-3 (M.W. 22 kDa), S-4 (M.W. 11.7 kDa) and S-5 (M.W. 9.3 kDa), in a molar ratio of 1:1:1:2:1;Pertussis toxin from Bordetella pertussis,Histamine-sensitizing factor, IAP, Islet Activating Protein, Pertussigen;ANTI-ALKALINE PHOSPHATASE (ALPI) (CENTER antibody produced in rabbit;ANTI-MAGT1 (N-TERM) antibody produced in rabbit;IAG2;Implantation-associated protein
CAS:70323-44-3
MF:NULL
MW:0
EINECS:
Product Categories:G-Protein
Mol File:Mol File
PERTUSSIS TOXIN Chemical Properties
storage temp. 2-8°C
form lyophilized powder
Safety Information
Hazard Codes T,B,Xi
Risk Statements 23/24/25-36/37/38
Safety Statements 36/37/39-45-26
RIDADR UN 3462 6.1/PG 1
WGK Germany 3
RTECS XW5883750
F 10
HazardClass 6.1(a)
PackingGroup I
MSDS Information
ProviderLanguage
SigmaAldrich English
PERTUSSIS TOXIN Usage And Synthesis
UsesThe toxin is released from B. pertussis in an inactive form. When the pertussis toxin B oligomer binds to the cell membrane, the S1 subunit of its A protomer becomes activated, perhaps through the action of glutathione and ATP. A protocol for activating pertussis toxin in vitro is given by Kaslow, et al.
General DescriptionProduct is not activated. If activation is required, see Kaslow, et al., for suggested conditions.
Biochem/physiol ActionsPertussis toxin catalyzes the ADP-ribosylation of the α subunits of the heterotrimeric guanine nucleotide regulatory proteins Gi, Go, and Gt. This prevents the G protein heterotrimers from interacting with receptors, thus blocking their coupling and activation. Since the Gα subunits remain in their GDP-bound, inactive state, they are unable to inactivate adenylyl cyclase or open K+ channels.
Purification MethodsPurify the toxin by stepwise elution from 3 columns comprising Blue Sepharose, Phenyl Sepharose and hydroxylapatite, and the purity is checked by SDS-PAGE. [Svoboda et al. Anal Biochem 159 402 1986, Biochemistry 21 5516 1982, Biochem J 83 295 1978.]
PERTUSSIS TOXIN Preparation Products And Raw materials

Welcome!

Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.

  • NO. 18 ,Wujiang Road, Wulidian Street, Jiangbei District, Chongqing
  • +86-23-6139-8061 +86-13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

Name

phone

company

email

message

Read the full Disclaimer
Payment methods
Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye